Search Results - "Francois, Bergmann Jean"

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

    Supplemental parenteral nutrition in critically ill patients by Lopes, Amanda, Lloret Linares, Celia, Bergmann, Jean-François

    Published in The Lancet (British edition) (18-05-2013)
    “…[...]the intervention group, which received 28 kcal/kg per day through enteral nutrition plus 10 kcal/kg per day parenterally, has a significantly lower rate…”
    Get full text
    Journal Article
  7. 7

    Suboptimal management of rheumatoid arthritis in France: a real-world study based on data from the French National Health Data System by Gaujoux-Viala, Cécile, Bergmann, Jean-Francois, Goguillot, Mélanie, Mélaine, Asma, Guérin, Marie, Edouard, Alban, Bénard, Stève, Fautrel, Bruno

    Published in Rheumatic & musculoskeletal diseases open (01-10-2023)
    “…ObjectivesThe emergence of targeted therapy is changing rheumatoid arthritis (RA) management, but real-world data remain limited. This study aimed to describe…”
    Get full text
    Journal Article
  8. 8

    Mini-series: I. Basic science. Uncertainty and inaccuracy of predicting CYP-mediated in vivo drug interactions in the ICU from in vitro models: focus on CYP3A4 by Mouly, Stéphane, Meune, Christophe, Bergmann, Jean-François

    Published in Intensive care medicine (01-03-2009)
    “…Drug–drug interactions (DDIs) contribute significantly to the incidence of adverse drug reactions. Important advances in the knowledge of human…”
    Get full text
    Journal Article
  9. 9

    Skin lightening and its complications among African people living in Paris by Petit, Antoine, Cohen-Ludmann, Cécile, Clevenbergh, Philippe, Bergmann, Jean-François, Dubertret, Louis

    “…Complications caused by skin lightening practices have not been systematically studied in Europe. Our aim was to assess the complications of skin lightening…”
    Get full text
    Journal Article
  10. 10

    Intravitreal Triamcinolone Acetonide for Diffuse Diabetic Macular Edema: Phase 2 Trial Comparing 4 mg vs 2 mg by Audren, François, Lecleire-Collet, Amélie, Erginay, Ali, Haouchine, Belkacem, Benosman, Rym, Bergmann, Jean-François, Gaudric, Alain, Massin, Pascale

    Published in American journal of ophthalmology (01-11-2006)
    “…To prospectively compare the efficacy and safety of 4 vs 2 mg intravitreal triamcinolone acetonide (TA) injection for diabetic macular edema. Interventional…”
    Get full text
    Journal Article
  11. 11

    Improving Practices in US Hospitals to Prevent Venous Thromboembolism: Lessons from ENDORSE by Anderson, Frederick A., PhD, Goldhaber, Samuel Z., MD, Tapson, Victor F., MD, Bergmann, Jean-Francois, MD, Kakkar, Ajay K., MD, Deslandes, Bruno, MD, Huang, Wei, MS, Cohen, Alexander T., MD

    Published in The American journal of medicine (01-12-2010)
    “…Abstract Background Venous thromboembolism prophylaxis is suboptimal in the US despite long-standing evidence-based recommendations. The aim of this subset…”
    Get full text
    Journal Article
  12. 12

    Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation by Lafuente-Lafuente, Carmelo, Valembois, Lucie, Bergmann, Jean-François, Belmin, Joël

    Published in Cochrane database of systematic reviews (28-03-2015)
    “…Atrial fibrillation is the most frequent sustained arrhythmia. Atrial fibrillation frequently recurs after restoration of normal sinus rhythm. Antiarrhythmic…”
    Get more information
    Journal Article
  13. 13

    Low-Molecular-Weight Heparin and Mortality in Acutely Ill Medical Patients by Kakkar, Ajay K, Cimminiello, Claudio, Goldhaber, Samuel Z, Parakh, Rajiv, Wang, Chen, Bergmann, Jean-François

    Published in The New England journal of medicine (29-12-2011)
    “…Thromboprophylaxis with low-molecular-weight heparin is known to prevent deep-vein thrombosis in acutely ill medical patients. This large trial showed no…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Antiarrhythmic drugs for maintaining sinus rhythm after cardioversion of atrial fibrillation: a systematic review of randomized controlled trials by Lafuente-Lafuente, Carmelo, Mouly, Stéphane, Longás-Tejero, Miguel Angel, Mahé, Isabelle, Bergmann, Jean-François

    Published in Archives of internal medicine (1960) (10-04-2006)
    “…A variety of antiarrhythmic drugs have been used to prevent recurrence of atrial fibrillation after conversion to sinus rhythm. We performed a systematic…”
    Get more information
    Journal Article
  16. 16
  17. 17

    Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation by Lafuente-Lafuente, Carmelo, Longas-Tejero, Miguel Angel, Bergmann, Jean-François, Belmin, Joël

    Published in Cochrane database of systematic reviews (16-05-2012)
    “…Atrial fibrillation (AF) is the most frequent sustained arrhythmia. AF recurs frequently after restoration of normal sinus rhythm. Antiarrhythmic drugs have…”
    Get more information
    Journal Article
  18. 18

    Etiologies and Management of Aseptic Meningitis in Patients Admitted to an Internal Medicine Department by Jarrin, Irène, Sellier, Pierre, Lopes, Amanda, Morgand, Marjolaine, Makovec, Tamara, Delcey, Veronique, Champion, Karine, Simoneau, Guy, Green, Andrew, Mouly, Stéphane, Bergmann, Jean-François, Lloret-Linares, Célia

    Published in Medicine (Baltimore) (01-01-2016)
    “…Several studies have focused on the clinical and biological characteristics of meningitis in order to distinguish between bacterial and viral meningitis in the…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Self-medication: from European regulatory directives to therapeutic strategy by Bergmann, Jean-François

    Published in Fundamental & clinical pharmacology (01-06-2003)
    “…Self medications are drugs which can be used without a physician's advice or supervision. There is a clear emerging patient demand for efficient drugs…”
    Get full text
    Journal Article